Market News AIOpen the app

CMMB stock news · Chemomab Therapeutics

Stories about Chemomab Therapeutics (CMMB) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for CMMB

Follow Chemomab Therapeutics (CMMB) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for CMMB
Free on the App Store and Google Play, or on the web.
  1. Nov 21, 2026, 2:03 AM ET · Trial

    Chemomab Therapeutics reported a loss last quarter and shared news about its merger and FDA trial plans.

    Neutral

    Chemomab reported a $5.1 million third-quarter loss, up from $1.7 million a year earlier, and shared updates on its proposed Scipher merger and FDA talks. The mixed news does not clearly change its outlook.

  2. Sep 30, 2026, 1:17 PM ET · Market

    12 health care companies are seeing big changes in their stock prices today.

    Neutral

    Chemomab Therapeutics shares fell 23% to $1.24. The article gives no company news explaining the move, so it does not change the business outlook.